Published by Unseen Progress, an independent publisher of caregiver research. Last reviewed 2026-05-10. Part of the Down syndrome research overview.
Short answer. Roughly 40 to 50 percent of children born with Down syndrome have a congenital heart defect (Bull et al., 2022; Freeman et al., 2008). The most common defects are atrioventricular septal defect (AVSD), ventricular septal defect (VSD), and atrial septal defect (ASD). The AAP Health Supervision schedule recommends a pediatric cardiology echocardiogram within the first month of life for every infant with Down syndrome, with structured follow-up across childhood and into adulthood. Cardiac status is the single largest medical factor shaping the early developmental trajectory.
The cardiac comorbidity load in Down syndrome is among the best-documented in clinical medicine. Population-level studies of Down syndrome cohorts converge on a 40 to 50 percent rate of congenital heart disease at birth (Freeman et al., 2008; Bull et al., 2022; Capone et al., 2018). The defect distribution differs from the general population. Atrioventricular septal defects — rare in the typically developing population — account for roughly 40 to 45 percent of Down syndrome cardiac diagnoses. Ventricular septal defects account for roughly 30 percent, atrial septal defects for roughly 15 percent, and tetralogy of Fallot, persistent ductus arteriosus, and other defects for the remainder.
The clinical implication is that Down syndrome cardiac screening cannot be deferred. Some defects, especially AVSD, can be silent on physical exam in the newborn period and produce heart failure as pulmonary vascular resistance falls in the first weeks of life. Echocardiography is the standard of care because it is the only tool that reliably catches the silent defects.
The Bull et al. (2022) Health Supervision schedule for children with Down syndrome — the contemporary clinical reference — specifies a structured cardiac monitoring cadence:
A pediatric cardiology echocardiogram by a cardiologist experienced with congenital heart disease should be performed in the first month of life regardless of physical exam findings. Newborn echo is the primary screening event. Where a defect is found, surgical repair is typically scheduled in the first three to six months of life — earlier for AVSD with significant shunt, later for smaller defects.
Follow-up cardiology is structured around the defect. Children with surgically repaired AVSD or VSD are typically followed annually or biannually. Children with no defect at newborn echo do not require routine pediatric cardiology follow-up but should have cardiac status reviewed at any new symptom, before any procedure requiring sedation, and at the transition to adult care.
Adult cardiology care is recommended starting in adolescence. Adults with Down syndrome — even those without congenital heart disease — have elevated rates of mitral and aortic valve disease that emerge in adulthood, and the Bull et al. (2022) guidelines recommend an adult cardiology baseline by the early twenties.
A common surprise for new Down syndrome parents is the degree to which the early developmental timeline is set by the cardiac picture, not by therapy intensity. A child with an unrepaired AVSD in heart failure has limited energy reserve, eats poorly, sleeps poorly, and gains weight slowly. Therapy productivity in that period is structurally lower regardless of the therapist or method. The same child after successful repair often has a visible developmental acceleration as caloric intake stabilises and energy returns.
The implication for parents is that cardiac status should be tracked alongside developmental progress. A quarter that included cardiac surgery and recovery is not a quarter to evaluate therapy productivity in. A quarter six months after repair, when the child has stabilised, is.
The AAP Health Supervision framework explicitly anticipates this by sequencing the medical and developmental schedules together: cardiac echo in month one, hearing screen by month six, thyroid annually, with developmental therapy running continuously around them.
A normal newborn physical exam. Many clinically significant Down syndrome cardiac defects are not audible at birth.
A pink, vigorous-looking newborn. Pulmonary vascular resistance is high in the first days of life and many shunts are silent until it falls.
The absence of feeding difficulty. Feeding difficulty is a late sign in many Down syndrome cardiac defects.
A normal pulse oximetry. Critical congenital heart disease screening with pulse oximetry catches some Down syndrome defects but is not designed to catch the AVSD-spectrum defects most common in DS.
The only tool that reliably distinguishes the cardiac status of a Down syndrome newborn is the formal echocardiogram (Bull et al., 2022).
Schedule the pediatric cardiology echocardiogram in the first month of life regardless of how the newborn looks on exam. Keep a written cardiac record — defect (if any), surgical date, current medications, follow-up cadence — that travels with the child to every new provider, because cardiac status is the first question every new specialist will ask. Track developmental progress in quarter-level windows that are aware of the cardiac calendar; recovery quarters are not evaluation quarters. Schedule the adult cardiology baseline before age 22, even in a child with no infant defect, because the adult valvular issues are common enough that the Bull et al. (2022) framework treats baseline as standard of care.
---
Unseen Progress publishes long-form caregiver research and builds research-backed daily trackers for the families covered. See the full Down syndrome research overview for the complete framework.